Psychemedics Corporation Stock News

21% YoY revenue growth in Q4, gross margins surge 1,000 bps YoY. EPS loss of $0.29 on higher legal costs and a one-time expense.

ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced today fourth quarter and full ye

ACTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, is pleased to welcome Andrew “Drew” M.

Psychemedics Co. (NASDAQ:PMD) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $7.22. Psychemedics shares last traded at $7.22, with a volume of 5,375 shares traded. Separately, TheStreet upgraded shares of Psychemedics from a d+ rating to a []

ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced that it has declared a cash

ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced that it has declared a cash dividend of $0.05 per share to be paid on December 30 th , 2021 to shareholders of record as of December 20 th , 2021.

Psychemedics (NASDAQ: PMD) is one of 42 publicly-traded companies in the Medical laboratories industry, but how does it weigh in compared to its competitors? We will compare Psychemedics to similar businesses based on the strength of its institutional ownership, analyst recommendations, profitability, risk, dividends, valuation and earnings. Insider & Institutional Ownership 40.6% of Psychemedics shares []

In this week's newsletter, we look at a company in the middle of monetizing its major asset to see what is left after the deal closes. We also review a shipping company that has built a strong margin

Psychemedics (NASDAQ: PMD) is one of 42 publicly-traded companies in the Medical laboratories industry, but how does it contrast to its peers? We will compare Psychemedics to similar businesses based on the strength of its valuation, dividends, risk, earnings, analyst recommendations, institutional ownership and profitability. Valuation & Earnings This table compares Psychemedics and its peers []

Psychemedics (NASDAQ: PMD) is one of 42 public companies in the Medical laboratories industry, but how does it compare to its rivals? We will compare Psychemedics to similar companies based on the strength of its dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings. Profitability This table compares Psychemedics and its rivals net margins, []

Psychemedics (NASDAQ: PMD) is one of 42 public companies in the Medical laboratories industry, but how does it contrast to its rivals? We will compare Psychemedics to related companies based on the strength of its profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations. Profitability This table compares Psychemedics and its rivals net margins, []

Psychemedics (NASDAQ: PMD) is one of 42 publicly-traded companies in the Medical laboratories industry, but how does it compare to its competitors? We will compare Psychemedics to similar businesses based on the strength of its valuation, dividends, risk, analyst recommendations, earnings, profitability and institutional ownership. Insider & Institutional Ownership 40.6% of Psychemedics shares are owned []

Psychemedics (NASDAQ: PMD) is one of 42 publicly-traded companies in the Medical laboratories industry, but how does it contrast to its peers? We will compare Psychemedics to related companies based on the strength of its valuation, earnings, profitability, dividends, institutional ownership, risk and analyst recommendations. Analyst Ratings This is a summary of recent recommendations for []

Psychemedics (NASDAQ: PMD) is one of 42 public companies in the Medical laboratories industry, but how does it compare to its rivals? We will compare Psychemedics to related businesses based on the strength of its earnings, dividends, profitability, risk, valuation, analyst recommendations and institutional ownership. Profitability This table compares Psychemedics and its rivals net margins, []